Analyst firms · Citigroup · REGN
Citigroup REGN price target and rating history
Regeneron Pharmaceuticals Inc. (REGN) · Health Care
Citigroup rates Regeneron Pharmaceuticals Inc. (REGN) Neutral with a $700 price target, as of its latest action on May 18, 2026. It has published 3 rating actions on REGN since November 2024, including 1 upgrade and 1 downgrade. Across 10 firms with a REGN price target in the last 12 months, the median target is $782.50. Citigroup's $700 is 11% below that.
- Current rating
- Neutral
- Price target
- $700
- Median target, all firms
- $782.50
- Actions on REGN
- 3
Citigroup price target on REGN
Every Citigroup rating on REGN
- May 18, 2026
- May 14, 2025
- Nov 14, 2024
How other firms rate REGN
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Argus Research | Buy | $850 | Oct 1, 2026 |
| Citigroup | Neutral | $700 | May 18, 2026 |
| Leerink Partners | Market Perform | $641 | May 18, 2026 |
| Piper Sandler | Overweight | $875 | Mar 31, 2026 |
| Barclays | Overweight | $923 | Mar 6, 2026 |
| BofA Securities | Buy | $860 | Jan 7, 2026 |
| Morgan Stanley | Equal-Weight | $767 | Dec 3, 2025 |
| Truist Securities | Buy | $798 | Nov 24, 2025 |
| HSBC | Buy | $255 | Nov 24, 2025 |
| Scotiabank | Sector Perform | $650 | Nov 13, 2025 |
Questions about Citigroup and REGN
- What is Citigroup's price target for REGN?
- Citigroup's latest stated price target for Regeneron Pharmaceuticals Inc. (REGN) is $700, from its action on May 18, 2026.
- What is Citigroup's rating on REGN?
- Citigroup rates REGN Neutral, a neutral rating, as of May 18, 2026.
- When did Citigroup last change its view on REGN?
- On May 18, 2026, Citigroup downgrades to Neutral from Buy, price target $700.
- How does Citigroup's REGN target compare with other analysts?
- Across 10 firms with a REGN price target in the last 12 months, the median target is $782.50. Citigroup's $700 is 11% below that.
More REGN rating histories
- Leerink Partners9
- BofA Securities3
- Morgan Stanley7
- Truist Securities3
- Bernstein3
- Raymond James3
- Oppenheimer3
- Jefferies3
- The Benchmark Company3
- H.C. Wainwright5
All Citigroup ratingsREGN news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.